These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23573647)

  • 1. Tackling complex cases in the drug-eluting stents era: where are we now?
    Holmes D
    J Invasive Cardiol; 2004 Sep; 16 Suppl F():8F-11F; discussion 18F-21F. PubMed ID: 23573647
    [No Abstract]   [Full Text] [Related]  

  • 2. The challenge of high-risk patients: diabetes and small vessels.
    Kereiakes D
    J Invasive Cardiol; 2004 Sep; 16 Suppl F():3F-7F; discussion 18F-21F. PubMed ID: 23573646
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-eluting stents.
    Whitlow P
    J Invasive Cardiol; 2004 Jul; 16(7 Suppl):2S-6S. PubMed ID: 23573564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug eluting stents for saphenous vein graft interventions.
    Banerjee S; Master R; Iqbal A; Brilakis ES
    Minerva Cardioangiol; 2011 Jun; 59(3):235-8. PubMed ID: 21516072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.
    Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S
    Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of rapamycin as compared to paclitaxel-eluting stents: a meta-analysis.
    Juwana YB; Rasoul S; Ottervanger JP; Suryapranata H
    J Invasive Cardiol; 2010 Jul; 22(7):312-6. PubMed ID: 20603502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting stents during ST-segment elevation acute myocardial infarction: a critical analysis.
    Andrade PB; Tebet MA; Silva FS; Andrade MV; Labrunie A; Piva e Mattos LA
    J Interv Cardiol; 2011 Oct; 24(5):416-23. PubMed ID: 21539610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug eluting stents in CTOs: why not?
    Vetrovec GW
    Catheter Cardiovasc Interv; 2011 Feb; 77(3):333-4. PubMed ID: 21328678
    [No Abstract]   [Full Text] [Related]  

  • 9. Rotational atherectomy with drug-eluting stents: a necessary technique in the current era.
    Lozano I; Rondan J; Avanzas P
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):160; author reply 161. PubMed ID: 21069801
    [No Abstract]   [Full Text] [Related]  

  • 10. Sirolimus-eluting stents versus paclitaxel-eluting stents in patients with chronic renal insufficiency.
    Syed AI; Ben-Dor I; Collins SD; Gonzalez MA; Gaglia MA; Torguson R; Satler LF; Suddath WO; Pichard AD; Lindsay J; Waksman R
    J Interv Cardiol; 2010 Feb; 23(1):33-9. PubMed ID: 20465718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous inflation of two drug-eluting balloons for the treatment of coronary bifurcation restenosis: a concept series.
    Sgueglia GA; Todaro D; Stipo A; Pucci E
    J Invasive Cardiol; 2011 Nov; 23(11):474-6. PubMed ID: 22045082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards defining the role of drug eluting stents.
    Tarantini G; Ramondo A; Razzolini R
    Minerva Cardioangiol; 2008 Feb; 56(1):29-34. PubMed ID: 18432166
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.
    Hannan EL; Wu C; Walford G; Culliford AT; Gold JP; Smith CR; Higgins RS; Carlson RE; Jones RH
    N Engl J Med; 2008 Jan; 358(4):331-41. PubMed ID: 18216353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome observations with drug-eluting stents.
    Steffenino G; Olivari Z
    J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):110-2. PubMed ID: 18192800
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden.
    James SK; Stenestrand U; Lindbäck J; Carlsson J; Scherstén F; Nilsson T; Wallentin L; Lagerqvist B;
    N Engl J Med; 2009 May; 360(19):1933-45. PubMed ID: 19420363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    Stenestrand U; James SK; Lindbäck J; Fröbert O; Carlsson J; Scherstén F; Nilsson T; Lagerqvist B;
    Eur Heart J; 2010 Jan; 31(2):177-86. PubMed ID: 19903684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.
    Dibra A; Kastrati A; Mehilli J; Pache J; Schühlen H; von Beckerath N; Ulm K; Wessely R; Dirschinger J; Schömig A;
    N Engl J Med; 2005 Aug; 353(7):663-70. PubMed ID: 16105990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Another small step for small vessels.
    Morrison DA
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):67-9. PubMed ID: 20578195
    [No Abstract]   [Full Text] [Related]  

  • 20. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.
    Windecker S; Remondino A; Eberli FR; Jüni P; Räber L; Wenaweser P; Togni M; Billinger M; Tüller D; Seiler C; Roffi M; Corti R; Sütsch G; Maier W; Lüscher T; Hess OM; Egger M; Meier B
    N Engl J Med; 2005 Aug; 353(7):653-62. PubMed ID: 16105989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.